The director of the department of ”Business operations, strategic and organizational development” at “Sopharma” AD, Mr. Vladimir Afenliev, was unanimously elected at the general assembly of “MEDICINES FOR EUROPE” (the former EGA) held at the end of June in Lisbon. This is the third consecutive mandate for Mr. Afenliev; during the previous term he also served as vice-president of the Executive bureau.
The election of Mr. Afenliev is an impressive recognition of the active role of “SOPHARMA” as a full member of the Association being, at the same time, one of the fastest growing regional leaders in Central and Eastern Europe. As a member of the Executive bureau during his the previous term, Mr. Afeneliev was also the chairman of a group working on the development of the market environment and market access in the CEE – an activity which will most probably be continued during the new mandate too.
Mr. Aflenliev has an extensive 28 years of experience in holding leading positions in the pharmaceutical industry and in the past he has worked for several multinational original and generic companies.